Document Detail

Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.
MedLine Citation:
PMID:  12730539     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To assess the evolution of disease subgroups and the frequency of progression of peripheral joint disease in a prospectively studied cohort of patients with psoriatic arthritis (PsA). METHODS: The cohort was identified as the first consecutive 100 patients attending a psoriatic arthritis clinic and who had been the subject of a previously published cross-sectional retrospective study. Nine of the 100 patients had died, three declined follow-up and one could not be traced. The remaining 87 patients (49 females, 38 males) completed the study proforma at a median follow-up interval of 65 months (range 39-90). An analysis of initial plasma viscosity compared with rates of progression of joint score was performed. RESULTS: Eighteen patients changed subgroup; 11 had an increase in the number of joints involved, six a decrease, and one changed from an oligoarticular pattern to predominant spondylitis. Within the polyarticular group 37/51 patients had an increase in the number of joints involved. For the whole population, there were significant increases in the number of joints involved (median 6 vs 11, P < 0.001 Wilcoxon signed rank) and Health Assessment Questionnaire scores (median 0.375 vs 0.5, P < 0.001). The median rate of joint progression was 0.42 peripheral joints per year (range 0-7.2). However, the rate of peripheral joint involvement was highest in the first year of arthritis (median 4.0 joints/yr) as measured in 13 patients who had onset within 12 months of baseline assessment. There were no significant differences in skin and nail scores although nine more patients had developed nail disease. There was a significant correlation between the initial viscosity and rate of progression of joint damage (Spearman correlation, P < 0.011). CONCLUSIONS: Peripheral joint disease is progressive in the majority of patients with PsA and reinforces the need for effective monitoring and treatment.
N J McHugh; C Balachrishnan; S M Jones
Related Documents :
3372759 - Frequency of skeletal disease, arthro-osteitis, in patients with pustulosis palmoplanta...
16200679 - Ultrasonography of the temporomandibular joint: comparison of findings in patients with...
14612629 - Functional outcome of patients with rotationplasty about the knee.
7968479 - Osteonecrosis of the femoral head in immunosuppressed patients: hip salvaging with impl...
24582719 - Antagonism of substance p and perception of breathlessness in patients with chronic obs...
16205149 - Radial osteotomies for teenage patients with kienböck disease.
21670399 - Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.
569779 - Clinical features of subcortical arteriosclerotic encephalopathy (binswanger disease).
266889 - The complement system in infectious mononucleosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2003-03-14
Journal Detail:
Title:  Rheumatology (Oxford, England)     Volume:  42     ISSN:  1462-0324     ISO Abbreviation:  Rheumatology (Oxford)     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-05-28     Completed Date:  2003-07-18     Revised Date:  2007-09-06    
Medline Journal Info:
Nlm Unique ID:  100883501     Medline TA:  Rheumatology (Oxford)     Country:  England    
Other Details:
Languages:  eng     Pagination:  778-83     Citation Subset:  AIM; IM    
Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age of Onset
Aged, 80 and over
Antirheumatic Agents / administration & dosage
Arthritis, Psoriatic / drug therapy,  pathology*,  physiopathology
Biological Markers / blood
Child, Preschool
Disease Progression
Follow-Up Studies
Middle Aged
Nail Diseases / pathology
Prospective Studies
Severity of Illness Index
Survival Rate
Reg. No./Substance:
0/Antirheumatic Agents; 0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in sys...
Next Document:  Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in v...